← All stories
Alumis
Pharmaceutical Preparations · US
- HQ
- SOUTH SAN FRANCISCO, CA
- Industry
- Pharmaceutical Preparations
- Country
- US
In the news · 2
Alumis’ TYK2 drug fails in key lupus study
Though Alumis still sees a path forward in lupus, the result made its drug the latest TYK2 blocker to struggle in conditions beyond psoriasis and psoriatic arthritis.
1 source
·4h ago
More in Healthcare